Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,159 | 13,833 | 19,286 | -10,927 | -771 |
| Depreciation Amortization | 4,082 | 2,085 | 987 | 3,394 | 2,474 |
| Income taxes - deferred | 183 | 131 | 180 | -1,242 | -3,538 |
| Accounts receivable | -15,215 | -9,200 | -4,660 | -2,195 | -4,195 |
| Accounts payable and accrued liabilities | -4,404 | -1,658 | -2,963 | 2,916 | 6,250 |
| Other Working Capital | -15,323 | -7,722 | -7,993 | -14,489 | -1,809 |
| Other Operating Activity | -28,241 | -24,829 | -21,818 | -10,137 | -7,756 |
| Operating Cash Flow | $-47,759 | $-27,360 | $-16,981 | $-32,680 | $-9,345 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,534 | -2,344 | -1,002 | -2,847 | -1,976 |
| Net Acquisitions | -8,107 | -8,920 | N/A | -9,107 | -827 |
| Purchase Of Investment | -87,402 | N/A | 0 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -200 | -200 |
| Other Investing Activity | 0 | 0 | 0 | -200 | -200 |
| Investing Cash Flow | $-99,043 | $-11,264 | $-1,002 | $-12,154 | $-3,003 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 110,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -39 | -26 | -13 | -7,251 | -2,118 |
| Common Stock Issued | 416 | 337 | N/A | N/A | 0 |
| Common Stock Repurchased | -9,000 | -9,000 | N/A | N/A | 0 |
| Other Financing Activity | -8,324 | -3,653 | -1,644 | 161,261 | 20,000 |
| Financing Cash Flow | $93,053 | $-12,342 | $-1,657 | $154,010 | $17,882 |
| Beginning Cash Position | 115,174 | 115,174 | 115,174 | 5,998 | 5,998 |
| End Cash Position | 61,425 | 64,208 | 95,534 | 115,174 | 11,532 |
| Net Cash Flow | $-53,749 | $-50,966 | $-19,640 | $109,176 | $5,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,759 | -27,360 | -16,981 | -32,680 | -9,345 |
| Capital Expenditure | -3,534 | -2,344 | -1,002 | -2,847 | -1,976 |
| Free Cash Flow | -51,293 | -29,704 | -17,983 | -35,527 | -11,321 |